Literature DB >> 31250024

Live-Attenuated Influenza Vaccine Induces Tonsillar Follicular T Helper Cell Responses That Correlate With Antibody Induction.

Sarah Lartey1, Fan Zhou1,2, Karl A Brokstad3, Kristin G-I Mohn1, Steffen A Slettevoll1, Rishi D Pathirana1, Rebecca J Cox1,2,4.   

Abstract

BACKGROUND: Influenza remains a major threat to public health. Live-attenuated influenza vaccines (LAIV) have been shown to be effective, particularly in children. Follicular T helper (TFH) cells provide B-cell help and are crucial for generating long-term humoral immunity. However the role of TFH cells in LAIV-induced immune responses is unknown.
METHODS: We collected tonsils, plasma, and saliva samples from children and adults receiving LAIV prior to tonsillectomy. We measured influenza-specific TFH-cell responses after LAIV by flow cytometry and immunohistochemistry. Systemic and local antibody responses were analysed by hemagglutination inhibition assay and enzyme-linked immunosorbent assay.
RESULTS: We report that LAIV induced early (3-7 days post-vaccination) activation of tonsillar follicles and influenza-specific TFH-cell (CXCR5+CD57+CD4+ T cell) responses in children, and to a lesser extent in adults. Serological analyses showed that LAIV elicited rapid (day 14) and long-term (up to 1 year post-vaccination) antibody responses (hemagglutination inhibition, influenza-specific IgG) in children, but not adults. There was an inverse correlation between pre-existing influenza-specific salivary IgA concentrations and tonsillar TFH-cell responses, and a positive correlation between tonsillar TFH-cell and systemic IgG induction after LAIV.
CONCLUSIONS: Our data, taken together, demonstrate an important role of tonsillar TFH cells in LAIV-induced immunity in humans.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

Entities:  

Keywords:  LAIV; TFH cells; antibody responses; influenza; tonsils

Year:  2020        PMID: 31250024     DOI: 10.1093/infdis/jiz321

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.

Authors:  K G-I Mohn; K A Brokstad; S Islam; F Oftung; C Tøndel; H J Aarstad; R J Cox
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

Review 2.  T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine.

Authors:  Anna Schmidt; Dennis Lapuente
Journal:  Viruses       Date:  2021-01-28       Impact factor: 5.048

3.  Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine.

Authors:  Lu Lu; Carol Ho-Yan Fong; Anna Jinxia Zhang; Wai-Lan Wu; Iris Can Li; Andrew Chak-Yiu Lee; Thrimendra Kaushika Dissanayake; Linlei Chen; Ivan Fan-Ngai Hung; Kwok-Hung Chan; Hin Chu; Kin-Hang Kok; Kwok-Yung Yuen; Kelvin Kai-Wang To
Journal:  Vaccines (Basel)       Date:  2020-12-11

Review 4.  Providing a Helping Hand: Metabolic Regulation of T Follicular Helper Cells and Their Association With Disease.

Authors:  Colleen L Mayberry; Natalie A Logan; John J Wilson; Chih-Hao Chang
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

5.  Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs.

Authors:  Barbara Holzer; Sophie B Morgan; Veronica Martini; Rajni Sharma; Becky Clark; Christopher Chiu; Francisco J Salguero; Elma Tchilian
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

6.  Protective Intranasal Immunization Against Influenza Virus in Infant Mice Is Dependent on IL-6.

Authors:  Elizabeth Ann Bonney; Kendall Krebs; Jihye Kim; Kirtika Prakash; Blake L Torrance; Laura Haynes; Mercedes Rincon
Journal:  Front Immunol       Date:  2020-10-28       Impact factor: 7.561

Review 7.  Mucosal vaccines - fortifying the frontiers.

Authors:  Ed C Lavelle; Ross W Ward
Journal:  Nat Rev Immunol       Date:  2021-07-26       Impact factor: 108.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.